Novel evidence that crosstalk between the complement, coagulation and fibrinolysis proteolytic cascades is involved in mobilization of hematopoietic stem/progenitor cells (HSPCs)

[1]  J. Lévesque,et al.  The novel CXCR4 antagonist POL5551 mobilizes hematopoietic stem and progenitor cells with greater efficiency than Plerixafor , 2013, Leukemia.

[2]  M. Ratajczak,et al.  Mobilization studies in C3-deficient mice unravel the involvement of a novel crosstalk between the coagulation and complement cascades in mobilization of hematopoietic stem/progenitor cells , 2013, Leukemia.

[3]  J. Lévesque,et al.  Hematopoietic stem cell mobilizing agents G-CSF, cyclophosphamide or AMD3100 have distinct mechanisms of action on bone marrow HSC niches and bone formation , 2012, Leukemia.

[4]  J. Born,et al.  Sleep and circadian rhythm regulate circulating complement factors and immunoregulatory properties of C5a , 2011, Brain, Behavior, and Immunity.

[5]  O. Kollet,et al.  The brain-bone-blood triad: traffic lights for stem-cell homing and mobilization. , 2010, Hematology. American Society of Hematology. Education Program.

[6]  J. Lévesque,et al.  The endosteal ‘osteoblastic’ niche and its role in hematopoietic stem cell homing and mobilization , 2010, Leukemia.

[7]  John D Lambris,et al.  Molecular Intercommunication between the Complement and Coagulation Systems , 2010, The Journal of Immunology.

[8]  M. Ratajczak,et al.  Innate immunity as orchestrator of stem cell mobilization , 2010, Leukemia.

[9]  M. Ratajczak,et al.  PLASMA SPHINGOSINE 1-PHOSPHATE IS A MAJOR CHEMOATTRACTANT THAT DIRECTS EGRESS OF HEMATOPOIETIC STEM PROGENITOR CELLS FROM BONE MARROW AND ITS LEVEL IN PERIPHERAL BLOOD INCREASES DURING MOBILIZATION DUE TO ACTIVATION OF COMPLEMENT CASCADE/MEMBRANE ATTACK COMPLEX , 2010, Leukemia.

[10]  M. Ratajczak,et al.  IMPAIRED MOBILIZATION OF HEMATOPOITEIC STEM/PROGENITOR CELLS IN C5-DEFCIENT MICE SUPPORTS THE PIVOTAL INVOLVEMENT OF INNATE IMMUNITY IN THIS PROCESS AND REVEALS NOVEL PROMOBILIZATION EFFECTS OF GRANULOCYTES , 2009, Leukemia.

[11]  P. Carmeliet,et al.  Membrane-anchored uPAR regulates the proliferation, marrow pool size, engraftment, and mobilization of mouse hematopoietic stem/progenitor cells. , 2009, The Journal of clinical investigation.

[12]  P. Carmeliet,et al.  Plasmin therapy enhances mobilization of HPCs after G-CSF. , 2008, Blood.

[13]  G. Rossi,et al.  In vivo activity of the cleaved form of soluble urokinase receptor: a new hematopoietic stem/progenitor cell mobilizer. , 2006, Cancer research.

[14]  J. Breslow.  n-3 fatty acids and cardiovascular disease. , 2006, The American journal of clinical nutrition.

[15]  P. Frenette,et al.  Signals from the Sympathetic Nervous System Regulate Hematopoietic Stem Cell Egress from Bone Marrow , 2006, Cell.

[16]  Robert Wolk,et al.  Sleep and cardiovascular disease. , 2005, Current problems in cardiology.

[17]  Christie M. Orschell,et al.  Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist , 2005, The Journal of experimental medicine.

[18]  T. Betsuyaku,et al.  Characterization of hematopoietic progenitor mobilization in protease-deficient mice. , 2004, Blood.

[19]  M. Ratajczak,et al.  Mobilization studies in mice deficient in either C3 or C3a receptor (C3aR) reveal a novel role for complement in retention of hematopoietic stem/progenitor cells in bone marrow. , 2004, Blood.

[20]  B. Williams,et al.  Mobilization by either cyclophosphamide or granulocyte colony-stimulating factor transforms the bone marrow into a highly proteolytic environment. , 2002, Experimental hematology.

[21]  R. Munro,et al.  The biological function of hementin in the proboscis of the leech Haementeria ghilianii. , 1991, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[22]  L. Patthy.  Evolution of blood coagulation and fibrinolysis. , 1990, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[23]  J. Dipersio,et al.  Advances in stem cell mobilization. , 2014, Blood reviews.

[24]  T. Papayannopoulou,et al.  Hematopoietic stem cell mobilization: updated conceptual renditions , 2013, Leukemia.

[25]  M. Ratajczak,et al.  A novel perspective on stem cell homing and mobilization: review on bioactive lipids as potent chemoattractants and cationic peptides as underappreciated modulators of responsiveness to SDF-1 gradients , 2012, Leukemia.

[26]  J. Chute,et al.  The vascular niche: home for normal and malignant hematopoietic stem cells , 2012, Leukemia.

[27]  L. Pelus,et al.  Hematopoietic stem cell mobilization with agents other than G-CSF. , 2012, Methods in molecular biology.

[28]  John D Lambris,et al.  Intercommunication between the Complement and Coagulation Systems , 2010 .